Strategic Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Strategic Investment Solutions’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.86K	Buy	11 +5	+83%	+$3.4K	﹤0.01%	475
2026 Q1	$4.64K	Hold	6	–	–	﹤0.01%	490
2025 Q4	$4.63K	Hold	6	–	–	﹤0.01%	483
2025 Q3	$3.37K	Hold	6	–	–	﹤0.01%	483
2025 Q2	$3.15K	Hold	6	–	–	﹤0.01%	471
2025 Q1	$3.81K	Sell	6 -3	-33%	-$2.06K	﹤0.01%	471
2024 Q4	$6.41K	Hold	9	–	–	﹤0.01%	435
2024 Q3	$9.46K	Buy	+9	New	+$10K	﹤0.01%	366
2023 Q4	$7.91K	Sell	9 -558	-98%	-$460K	﹤0.01%	793
2023 Q3	$446K	Buy	567 +558	+6,200%	+$439K	0.01%	409
2023 Q2	$6.58K	Hold	9	–	–	﹤0.01%	615
2023 Q1	$7.39K	Buy	+9	New	+$6.79K	﹤0.01%	690

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Strategic Investment Solutions's REGN Position: Q2 2026 in Review

Strategic Investment Solutions increased its Regeneron Pharmaceuticals (REGN) stake by 83% in Q2 2026, buying an estimated $3.4K and bringing the position to 11 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Strategic Investment Solutions first reported a position in REGN in Q1 2023 and has held it in 12 quarters since. The position peaked at $446K in Q3 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Strategic Investment Solutions held 11 shares of Regeneron Pharmaceuticals worth $6.86K as of Q2 2026.
Strategic Investment Solutions bought 5 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.4K.
Regeneron Pharmaceuticals made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #475 holding.
Strategic Investment Solutions first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
Strategic Investment Solutions's Regeneron Pharmaceuticals position peaked at $446K in Q3 2023.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.